Literature DB >> 16081918

Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-beta-lactamase.

Laura Pagani1, Céline Colinon, Roberta Migliavacca, Maria Labonia, Jean-Denis Docquier, Elisabetta Nucleo, Melissa Spalla, Michele Li Bergoli, Gian Maria Rossolini.   

Abstract

An outbreak of Pseudomonas aeruginosa showing a multidrug-resistant (MDR) phenotype (including carbapenems, ceftazidime, cefepime, gentamicin, tobramycin, and fluoroquinolones) was observed, during a 5-month period, in a general intensive care unit of a large tertiary care and clinical research hospital in southern Italy. The outbreak involved 15 patients, with a total of 87 isolates, mostly from lower respiratory tract specimens. Analysis of isolates involved in the outbreak revealed production of metallo-beta-lactamase (MBL) activity, and genotyping by pulsed-field gel electrophoresis of genomic DNA digested by SpeI revealed clonal relatedness among isolates. Molecular analysis of the MBL determinant showed the presence of a bla(IMP-13) gene carried on a gene cassette inserted in a class 1 integron which also contained an aacA4 aminoglycoside resistance cassette encoding an AAC(6')-Ib enzyme. The bla(IMP-13)-containing integron and its genetic environment appeared to be similar to those found in P. aeruginosa isolates producing IMP-13 from a hospital in Rome. The bla(IMP-13) gene was not transferable by conjugation and was apparently carried on the chromosome. The outbreak was coincidental with a shortage of nursing personnel, and resolution was apparently associated with reinstatement of nursing personnel and reinforcement of general infection control practices within the intensive care unit. To our best knowledge this is the first description of a nosocomial outbreak of relatively large size caused by an IMP-producing gram-negative pathogen in Europe.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081918      PMCID: PMC1233900          DOI: 10.1128/JCM.43.8.3824-3828.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

Review 1.  New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy.

Authors:  K Bush
Journal:  Clin Infect Dis       Date:  2001-03-21       Impact factor: 9.079

2.  Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.

Authors:  A Tsakris; S Pournaras; N Woodford; M F Palepou; G S Babini; J Douboyas; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

3.  IMP-1 carbapenemase detected in an Acinetobacter clinical isolate from the UK.

Authors:  Luke Tysall; Mark W Stockdale; Paul R Chadwick; Marie-France I Palepou; Kevin J Towner; David M Livermore; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

Review 4.  Carbapenemases: a problem in waiting?

Authors:  D M Livermore; N Woodford
Journal:  Curr Opin Microbiol       Date:  2000-10       Impact factor: 7.934

5.  IMP-12, a new plasmid-encoded metallo-beta-lactamase from a Pseudomonas putida clinical isolate.

Authors:  Jean-Denis Docquier; Maria Letizia Riccio; Claudia Mugnaioli; Francesco Luzzaro; Andrea Endimiani; Antonio Toniolo; Gianfranco Amicosante; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

6.  Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4.

Authors:  S Pournaras; M Maniati; E Petinaki; L S Tzouvelekis; A Tsakris; N J Legakis; A N Maniatis
Journal:  J Antimicrob Chemother       Date:  2003-04-25       Impact factor: 5.790

7.  Spread of integron-associated VIM-type metallo-beta-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals.

Authors:  P Giakkoupi; G Petrikkos; L S Tzouvelekis; S Tsonas; N J Legakis; A C Vatopoulos
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

8.  PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron.

Authors:  Naohiro Shibata; Yohei Doi; Kunikazu Yamane; Tetsuya Yagi; Hiroshi Kurokawa; Keigo Shibayama; Haru Kato; Kumiko Kai; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

9.  Infrequent detection of acquired metallo-beta-lactamases among carbapenem-resistant Pseudomonas isolates in a Greek hospital.

Authors:  A Tsakris; P T Tassios; F Polydorou; A Papa; E Malaka; A Antoniadis; N J Legakis
Journal:  Clin Microbiol Infect       Date:  2003-08       Impact factor: 8.067

10.  Genetic characterization of a novel metallo-beta-lactamase gene, blaIMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme.

Authors:  Mark A Toleman; Doug Biedenbach; David Bennett; Ronald N Jones; Timothy R Walsh
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790

View more
  30 in total

1.  Intercontinental dissemination of IMP-13-producing Pseudomonas aeruginosa belonging in sequence type 621.

Authors:  Gisela Santella; Simona Pollini; Jean-Denis Docquier; Ana Irina Mereuta; Gabriel Gutkind; Gian Maria Rossolini; Marcela Radice
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

2.  First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.

Authors:  Giuseppe Valenza; Biju Joseph; Johannes Elias; Heike Claus; Anett Oesterlein; Kathrin Engelhardt; Doris Turnwald; Matthias Frosch; Marianne Abele-Horn; Christoph Schoen
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

Review 3.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

4.  First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.

Authors:  Wojciech Duljasz; Marek Gniadkowski; Silvia Sitter; Alexandra Wojna; Crista Jebelean
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

5.  Biological markers of Pseudomonas aeruginosa epidemic high-risk clones.

Authors:  Xavier Mulet; Gabriel Cabot; Alain A Ocampo-Sosa; M Angeles Domínguez; Laura Zamorano; Carlos Juan; Fe Tubau; Cristina Rodríguez; Bartolomé Moyà; Carmen Peña; Luis Martínez-Martínez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

6.  Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.

Authors:  Luisa Borgianni; Silvia Prandi; Laurie Salden; Gisela Santella; Nancy D Hanson; Gian Maria Rossolini; Jean-Denis Docquier
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

7.  Full Resistance and decreased susceptibility to carbapenems in IMP-13-producing Pseudomonas aeruginosa isolates from an outbreak.

Authors:  Gisela Santella; Arabela Cuirolo; Marisa Almuzara; Susana Palombarani; Gabriela Sly; Marcela Radice; Gabriel Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2010-01-04       Impact factor: 5.191

8.  First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.

Authors:  Gian Maria Rossolini; Francesco Luzzaro; Roberta Migliavacca; Claudia Mugnaioli; Beatrice Pini; Filomena De Luca; Mariagrazia Perilli; Simona Pollini; Melissa Spalla; Gianfranco Amicosante; Antonio Toniolo; Laura Pagani
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

9.  Spread of multidrug-resistant Pseudomonas aeruginosa clones in a university hospital.

Authors:  Maria Koutsogiannou; Eleanna Drougka; Apostolos Liakopoulos; Eleni Jelastopulu; Efthimia Petinaki; Evangelos D Anastassiou; Iris Spiliopoulou; Myrto Christofidou
Journal:  J Clin Microbiol       Date:  2012-12-12       Impact factor: 5.948

10.  Acute, multiple-dose dermal and genetic toxicity of Nu-3: a novel antimicrobial agent.

Authors:  Juan Sun; Yanxin Hu; Shanping Cao; Guozhong Zhang; Lun-Quan Sun; Ming Wang
Journal:  J Biomed Biotechnol       Date:  2010-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.